Brenda Libby Coleman

Array ( [id] => 4746196 [patent_doc_number] => 20080090798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents' [patent_app_type] => utility [patent_app_number] => 11/954899 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29194 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090798.pdf [firstpage_image] =>[orig_patent_app_number] => 11954899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403871 [patent_doc_number] => 20100305316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PROCESSES FOR PREPARING (R)-8-CHLORO-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE AND INTERMEDIATES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/517625 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10893 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305316.pdf [firstpage_image] =>[orig_patent_app_number] => 12517625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833943 [patent_doc_number] => 20080132490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Substituted diazepan orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/998812 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21528 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132490.pdf [firstpage_image] =>[orig_patent_app_number] => 11998812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4692468 [patent_doc_number] => 20080085239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Aminoderivative of biotin and their conjugates with macrocyclic chelating agents' [patent_app_type] => utility [patent_app_number] => 11/987060 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4867 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085239.pdf [firstpage_image] =>[orig_patent_app_number] => 11987060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753213 [patent_doc_number] => 20080161288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/871345 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37105 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161288.pdf [firstpage_image] =>[orig_patent_app_number] => 11871345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318733 [patent_doc_number] => 07521443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/942285 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41448 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521443.pdf [firstpage_image] =>[orig_patent_app_number] => 11942285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880418 [patent_doc_number] => 20080153801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Benzoxazepine compounds, their production and use' [patent_app_type] => utility [patent_app_number] => 11/986280 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20962 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153801.pdf [firstpage_image] =>[orig_patent_app_number] => 11986280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494696 [patent_doc_number] => 20100009964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Compounds Which Modulate The CB2 Receptor' [patent_app_type] => utility [patent_app_number] => 12/513680 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29223 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009964.pdf [firstpage_image] =>[orig_patent_app_number] => 12513680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792693 [patent_doc_number] => 20080293667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Lipid analogs for combating tumors' [patent_app_type] => utility [patent_app_number] => 11/980819 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8258 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293667.pdf [firstpage_image] =>[orig_patent_app_number] => 11980819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760207 [patent_doc_number] => 20080312433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Novel process to Form-I of olanzapine' [patent_app_type] => utility [patent_app_number] => 11/976944 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2049 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312433.pdf [firstpage_image] =>[orig_patent_app_number] => 11976944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955441 [patent_doc_number] => 20080188465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Process of Preparation of Olanzapine Form I' [patent_app_type] => utility [patent_app_number] => 11/928791 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3688 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188465.pdf [firstpage_image] =>[orig_patent_app_number] => 11928791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965785 [patent_doc_number] => 20080108605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS' [patent_app_type] => utility [patent_app_number] => 11/929860 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26831 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108605.pdf [firstpage_image] =>[orig_patent_app_number] => 11929860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4445397 [patent_doc_number] => 07863442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Processes for the synthesis of olanzapine' [patent_app_type] => utility [patent_app_number] => 11/976978 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1930 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863442.pdf [firstpage_image] =>[orig_patent_app_number] => 11976978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771333 [patent_doc_number] => 20080056991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'PIPERAZINYL AND DIAZAPANYL BENZAMIDES AND BENZTHIOAMIDES' [patent_app_type] => utility [patent_app_number] => 11/928006 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18246 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20080056991.pdf [firstpage_image] =>[orig_patent_app_number] => 11928006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765623 [patent_doc_number] => 20080176835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Prenyl Transferase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/929118 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23210 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176835.pdf [firstpage_image] =>[orig_patent_app_number] => 11929118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4524079 [patent_doc_number] => 07951799 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Lactam compound, a method for producing the same, and a diabetic therapy by administering the same' [patent_app_type] => utility [patent_app_number] => 11/926745 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16233 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951799.pdf [firstpage_image] =>[orig_patent_app_number] => 11926745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189440 [patent_doc_number] => 08183273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Bicyclic compound, production and use thereof' [patent_app_type] => utility [patent_app_number] => 11/978198 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62575 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183273.pdf [firstpage_image] =>[orig_patent_app_number] => 11978198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701568 [patent_doc_number] => 08394790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Psychotropic agents having glutamate NMDA activity' [patent_app_type] => utility [patent_app_number] => 12/447381 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 52 [patent_no_of_words] => 18094 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12447381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446996 [patent_doc_number] => 20090048222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Triaza Compound Immunoregulatory Agents' [patent_app_type] => utility [patent_app_number] => 11/871416 [patent_app_country] => US [patent_app_date] => 2007-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14820 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048222.pdf [firstpage_image] =>[orig_patent_app_number] => 11871416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398360 [patent_doc_number] => 20090318423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Ion Channel Modulators & Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/443402 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21740 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318423.pdf [firstpage_image] =>[orig_patent_app_number] => 12443402 [rel_patent_id] =>[rel_patent_doc_number] =>)